Q-linea

About Q-linea AB (publ) 

Q-linea’s rapid AST system, ASTar®, accelerates and simplifies the time-sensitive workflows faced during the treatment of patients with bloodstream infections and sepsis. Hospitals use ASTar to vastly reduce the time to optimal antimicrobial therapies and ensure that patients receive the correct treatments sooner – when time matters most. Q-linea are helping to create sustainable healthcare, now and in the future, and safeguard the effectiveness of antibiotics for generations to come.  

Q-linea is headquartered in Uppsala, Sweden and has regional offices in Italy and the USA, with partnerships worldwide. ASTar Instrument and ASTar BC G- Consumable kit are CE-IVD marked and FDA 510(k) cleared. 

Press release 

Stuart Gander, CEO of Q-linea, comments: 

“We are pleased to see the continued strong support from our main owners as we continue our journey towards profitability.” 

Website: https://qlinea.com/